Blog

Josh Neman: Advancing frontiers of Clinical Trials, policy and research for patient

Photo taken from Josh Neman/X

Oct 12, 2024, 11:15

Josh Neman: Advancing frontiers of Clinical Trials, policy and research for patient

”Fantastic brain metastasis think tank National Cancer Institute. Advancing frontiers of Clinical Trials, and policy, research for patients!”

Josh Neman is the Director of Cancer Research Training and Education Coordination and Co-Leader of the Neuro-Oncology Disease Affinity Group at USC Norris Comprehensive Cancer Center. He is a tenured Associate Professor of Neurosurgery at Keck Medicine of USC and the Scientific Director of the USC Brain Tumor Center. Additionally, he serves as the Director of the Cancer Biology and Genomics Doctoral Program at USC PIBBS and is a member of the Scientific Advisory Board for the Breast Cancer Care and Research Fund.

American Brain Tumor Association brain metastasis Breast Cancer cancer clinical trials Jona Hattangadi-Gluth Josh Neman Lung cancer Melanie Hayden Gephart Melanoma National Cancer Institute NCI Neuro-Oncology Branch Nicole Willmarth OncoDaily Oncology research for patient Tatiana Prowell USC Brain Tumor Center (uscbtc) USC Norris Comprehensive Cancer Center

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage